A novel SHOC2 variant in rasopathy

Vickie Hannig, Myoungkun Jeoung, Eun Ryoung Jang, John A. Phillips, Emilia Galperin

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Rasopathies are a group of genetic disorders caused by germline mutations in multiple genes of the Extracellular signal-Regulated Kinases 1 and 2 (ERK1/2) pathway. The only previously identified missense mutation in SHOC2, a scaffold protein of the ERK1/2 pathway, led to Noonan-like syndrome with loose anagen hair. Here, we report a novel mutation in SHOC2(c.519G>A; p.M173I) that leads to a Rasopathy with clinical features partially overlapping those occurring in Noonan and cardiofaciocutaneous syndromes. Studies to clarify the significance of this SHOC2 variant revealed that the mutant protein has impaired capacity to interact with protein phosphatase 1c (PP1c), leading to insufficient activation of RAF-1 kinase. This SHOC2 variant thus is unable to fully rescue ERK1/2 activity in cells depleted of endogenous SHOC2. We conclude that SHOC2 mutations can cause a spectrum of Rasopathy phenotypes in heterozygous individuals. Importantly, our work suggests that individuals with mild Rasopathy symptoms may be underdiagnosed.

Original languageEnglish
Pages (from-to)1291-1294
Number of pages4
JournalHuman Mutation
Issue number11
StatePublished - Nov 1 2014

Bibliographical note

Publisher Copyright:
© 2014 Wiley Periodicals, Inc.


  • ERK1/2 pathway
  • Rasopathies
  • SHOC2
  • Signaling

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)


Dive into the research topics of 'A novel SHOC2 variant in rasopathy'. Together they form a unique fingerprint.

Cite this